A Phase 2 Study to Evaluate the Impact of MTP-131 (Bendavia™) on Skeletal Muscle Function in Elderly
Source · ClinicalTrials.gov: elamipretide
TLDR
ClinicalTrials.gov lists a completed Phase 2 study of MTP-131 (elamipretide) involving 41 elderly participants with previous evidence of mitochondrial dysfunction. The randomized, double-blind, placebo-controlled trial evaluated effects on hand skeletal muscle energetics or muscle performance; the excerpt provides no results.
- 01The trial enrolled elderly participants with prior evidence of mitochondrial dysfunction.
- 02Researchers evaluated muscle energetics or performance in age-related skeletal muscle mitochondrial dysfunction.
- 03Completed status is reported, but efficacy and safety findings are not provided.
Why it matters Editorial
The study addresses elamipretide’s potential effects on age-related muscle mitochondrial dysfunction, but the excerpt does not establish a benefit.
Summary generated with AI and reviewed by an editor. The original source governs; summaries can contain errors. Information only — not medical advice. Full disclaimer.
ClinicalTrials.gov: elamipretide
ClinicalTrials.gov: elamipretide
ClinicalTrials.gov: elamipretide
ClinicalTrials.gov: elamipretide